Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03302741 · ClinicalTrials.gov registry record · Phase 4

Imaging of 3D Innervation Zone Distribution in Spastic Muscles From High-density Surface EMG Recordings

A Phase 4 study of Spasticity, sponsored by The University of Texas Health Science Center, Houston.

Completed
Registry status
Phase 4
Development phase
17
Enrollment target
1
Study location

NCT03302741 is a Phase 4 study of Spasticity that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 17 participants, below the 90-participant average among 8 other Spasticity trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03302741, a Phase 4 study of Spasticity, has completed, sponsored by The University of Texas Health Science Center, Houston.

COMPLETED
Registry status
Phase 4
Development phase
17 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to evaluate if it is possible to use a new 3D imaging method to guide Botulinum neurotoxin (BTX) injection for muscle spasticity management after stroke. This imaging method is called three dimensional innervation zone imaging, or 3DIZI.

Conditions Studied

Interventions

  • OTHER Physical Therapy
  • DRUG Botulinum neurotoxin (BTX)
  • DEVICE Standard BTX injection (ultrasound guided)
  • DEVICE 3-dimensional innervation zone (3DIZ) guided injection

Study Locations (1)

Texas

  • The University of Texas Health Science Center at Houston - Houston

Trial Details

FieldValue
Enrollment Target 17 participants
Start Date 2017-11-21
Est. Completion 2019-11-18
Phase Phase 4

What the Registry Record Tells You About NCT03302741

The ClinicalTrials.gov registry entry for NCT03302741 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 90-participant average among 8 other Spasticity trials with a reported enrollment target (81% lower). The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Spasticity appearing as the primary indexed condition, and to 4 interventions - of which Physical Therapy is the first listed.

NCT03302741 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT03302741 about?

NCT03302741 is a clinical study titled "Imaging of 3D Innervation Zone Distribution in Spastic Muscles From High-density Surface EMG Recordings". The purpose of this study is to evaluate if it is possible to use a new 3D imaging method to guide Botulinum neurotoxin (BTX) injection for muscle spasticity management after stroke. This imaging method is called three dimensional innervation zone imaging, or 3DIZI.

What is the current status of trial NCT03302741?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 17 participants. The study started on 2017-11-21. Estimated completion is 2019-11-18.

What conditions does trial NCT03302741 study?

This clinical trial studies the following conditions: Spasticity.

What interventions are being tested in trial NCT03302741?

The interventions under investigation include: Physical Therapy (OTHER), Botulinum neurotoxin (BTX) (DRUG), Standard BTX injection (ultrasound guided) (DEVICE), 3-dimensional innervation zone (3DIZ) guided injection (DEVICE).

Who is sponsoring clinical trial NCT03302741?

This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03302741 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Spasticity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.